Your browser doesn't support javascript.
loading
Is the endotoxin-complement cascade the major driver in lipedema?
Kruglikov, Ilja L; Scherer, Philipp E.
Afiliación
  • Kruglikov IL; Scientific Department, Wellcomet GmbH, Karlsruhe, Germany.
  • Scherer PE; Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390-8549, USA. Electronic address: philipp.scherer@utsouthwestern.edu.
Trends Endocrinol Metab ; 35(9): 769-780, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38688780
ABSTRACT
Lipedema is a poorly understood disorder of adipose tissue characterized by abnormal but symmetrical deposition of subcutaneous white adipose tissue (WAT) in proximal extremities. Here, we propose that the underlying cause for lipedema could be triggered by a selective accumulation of bacterial lipopolysaccharides (LPS; also known as endotoxin) in gluteofemoral WAT. Together with a malfunctioning complement system, this induces low-grade inflammation in the depot and raises its uncontrollable expansion. Correspondingly, more attention should be paid in future research to the endotoxemia prevalent in patients with lipedema. We would like to propose that proper management of endotoxemia can reduce the progression and even improve the state of disease in patients with lipedema.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipedema Límite: Animals / Humans Idioma: En Revista: Trends Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipedema Límite: Animals / Humans Idioma: En Revista: Trends Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos